Profil
James R.
Piggott has been Senior Vice President of Pharmaceutical Biology for Lexicon Pharmaceuticals, Inc. since January 2000.
From 1990 to October 1999, he worked at ZymoGenetics, Inc., most recently as Senior Vice President-Research Biology from 1997 to October 1999.
Previously, Dr. Piggott worked at the Smith Kline & French Laboratories Ltd.
and the GD Searle & Co. He received a BA degree and a PhD from Trinity College.
Anciens postes connus de James R. Piggott
| Sociétés | Poste | Fin |
|---|---|---|
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 01/10/1999 |
| LEXICON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de James R. Piggott
| Trinity College Dublin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
